Comprehensive analysis of ZNF692 as a potential biomarker associated with immune infiltration in a pan cancer analysis and validation in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Comprehensive analysis of ZNF692 as a potential biomarker associated with immune infiltration in a pan cancer analysis and validation in hepatocellular carcinoma

Published:2023-11-17 Issue:22 Volume:15 Page:13041-13058
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Cai Hongjie¹,Chen Song²,Wu Zhiqiang¹,Wang Fan¹,Tang Shuangyan¹,Li Dongbing³,Wang Dongliang³,Guo Wenbo¹

Affiliation:

1. Department of Interventional Radiology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510062, Guangdong, China

2. Department of Minimally Invasive Interventional Therapy, Sun Yat-Sen University Cancer Center and Sun Yat-Sen University State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, Guangdong, China

3. Department of Translational Medicine, ChosenMed Technology (Beijing) Co., Ltd., Beijing 100176, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Reference32 articles.

1. Systematic analysis identifies XRCC4 as a potential immunological and prognostic biomarker associated with pan-cancer.;Tian;BMC Bioinformatics,2023

2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.;Bray;CA Cancer J Clin,2021

3. Pan-Cancer Analysis of the Prognostic and Immunological Role of HSF1: A Potential Target for Survival and Immunotherapy.;Tan;Oxid Med Cell Longev,2021

4. Cancer statistics, 2023.;Jemal;CA Cancer J Clin,2023

5. AMP-activated protein kinase regulates PEPCK gene expression by direct phosphorylation of a novel zinc finger transcription factor.;Yamauchi;Biochem Biophys Res Commun,2006

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RPL22L1 is a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma, promoting the growth and metastasis of LUAD cells by inhibiting the MDM2/P53 signaling pathway;Aging;2024-08-28

2. ZNF692 promotes the migration and response to immunotherapy of clear cell renal cell carcinoma cells by targeting metabolic pathway;Discover Oncology;2024-05-12

3. ZNF692 drives malignant development of hepatocellular carcinoma cells by promoting ALDOA-dependent glycolysis;Functional & Integrative Genomics;2024-03-08